AMP Principles for Health Care Reform

AMP priorities for Comparative Effectiveness Research (CER) (June 2009)

AMP comments to the SACGHS (June 2009)

AMP comments to the SACGHS draft report on gene patents (May 15, 2009)

Read the May 2009 issue of the AMP Newsletter

  The Association for Molecular Pathology Joins the American Civil Liberties Union to Challenge the Constitutionality of Gene Patents (May 13, 2009)

  AMP comments to the MEDCAC regarding evidence standards for screening tests (May 6, 2009)

  The Association for Molecular Pathology calls for enhanced communication and collaboration between state and local public health laboratories and molecular pathology laboratories to combat the swine influenza A (H1N1) outbreak (May 5, 2009)

  AMP recommends to the IOM priorities for Stimulus Bill spending on Comparative Effectiveness Research (CER)(March 27, 2009)

  The Clinical Practice Committee has issued new position statements and comments on:

ACMG’s Technical Standards and Guidelines for Myotonic Dystrophy Type 1 Testing

Genetic Ancestry Testing

NHGRI Regarding Long Range Planning

AMP will jointly present a Molecular Pathology Essentials course in Copenhagen in October 2009.

Read the February 2009 issue of the AMP Newsletter, now in HTML format.

The AMP Molecular Genetic Pathology Review Course will take place April 30 - May 3, 2009 in Rockville, MD.

Letter sent to the WHO endorsing reference materials for fragile X and other molecular tests.

New Position Statement: Gene Patents and the Exclusive Licensing of Genetic Discoveries.

The Clinical Practice Committee has released a catalogue of mutation database websites.

October Newsletter

CMS has announced that it will publish most of the edits used in its MUE program on its website.

AMP members Vicky Pratt, Terry Dunn and Karen Weck contribute article for Update magazine..
>> Click here to read the article

Victor Almon McKusick, M.D. (1921-2008)

We are saddened by the recent death of Dr. Victor McKusick.
>> Read More...

May Newsletter

AMP provides comments to FDA, NIGMS and the SACGHS.

AMP continues to support the Genetic Information Nondiscrimination Act (GINA).

February Newsletter

Comments to the SACGHS Task Force Draft Report Regarding Oversight of Genetic Testing.